Verastem, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Verastem, Inc. on May 30, 2023, regarding a corporate action approved by stockholders on May 15, 2023. The report details a material modification to the rights of security holders through a reverse stock split.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on capital structure changes rather than operational financial performance.
Material Changes
- Reverse Stock Split: The Company implemented a one-for-twelve (1:12) reverse stock split of its issued and outstanding common stock.
- Effective Date: The split became effective at 5:00 p.m. Eastern Time on May 31, 2023.
- Trading Resumption: Trading on a post-split basis commenced on June 1, 2023, under CUSIP number 92337C 203.
- Authorized Shares: The total number of authorized shares remains at 300,000,000.
- Fractional Shares: No fractional shares were issued; holders entitled to fractions received cash based on the closing price on May 30, 2023, adjusted for the split ratio.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure regarding the mechanics of the reverse stock split. The primary purpose of the filing was to disclose the amendment to the Restated Certificate of Incorporation.
Investor Verification Checklist
- Confirm the new CUSIP number (92337C 203) for post-split trading.
- Verify the adjusted share count in brokerage accounts following the 1:12 conversion.
- Check for cash payments received in lieu of fractional shares.
- Review the full text of the Certificate of Amendment (Exhibit 3.1) for any additional terms.